Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VEEV Stock Forecast 2025-2026
$235.00
Current Price
$39.24B
Market Cap
Buy 19
Hold 11
Sell 2
Wall St Analyst Ratings
Distance to VEEV Price Targets
+23.4%
To High Target of $290.00
+14.9%
To Median Target of $270.00
-14.5%
To Low Target of $201.00
VEEV Price Momentum
-2.7%
1 Week Change
+8.9%
1 Month Change
+14.2%
1 Year Change
+11.8%
Year-to-Date Change
-9.2%
From 52W High of $258.93
+38.0%
From 52W Low of $170.25
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Veeva (VEEV) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on VEEV and similar high-potential opportunities.
Latest VEEV Stock Price Targets & Analyst Predictions
Based on our analysis of 44 Wall Street analysts, VEEV has a bullish consensus with a median price target of $270.00 (ranging from $201.00 to $290.00). The overall analyst rating is Buy (7.8/10). Currently trading at $235.00, the median forecast implies a 14.9% upside. This outlook is supported by 19 Buy, 11 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Brent Bracelin at Piper Sandler, projecting a 23.4% upside. Conversely, the most conservative target is provided by Craig Hettenbach at Morgan Stanley, suggesting a 14.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VEEV Analyst Ratings
19
Buy
11
Hold
2
Sell
VEEV Price Target Range
Low
$201.00
Average
$270.00
High
$290.00
Current: $235.00
Latest VEEV Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VEEV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 23, 2025 | Piper Sandler | Brent Bracelin | Overweight | Maintains | $255.00 |
| Apr 16, 2025 | Keybanc | Sangita Jain | Overweight | Maintains | $250.00 |
| Mar 20, 2025 | JP Morgan | Anne Samuel | Neutral | Maintains | $249.00 |
| Mar 6, 2025 | Morgan Stanley | Craig Hettenbach | Underweight | Maintains | $201.00 |
| Mar 6, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $270.00 |
| Mar 6, 2025 | Truist Securities | Joe Meares | Hold | Maintains | $217.00 |
| Mar 6, 2025 | Scotiabank | Allan Verkhovski | Sector Perform | Maintains | $245.00 |
| Mar 6, 2025 | Stephens & Co. | Jeff Garro | Overweight | Reiterates | $280.00 |
| Mar 6, 2025 | Baird | Joe Vruwink | Outperform | Maintains | $285.00 |
| Jan 23, 2025 | Goldman Sachs | Gabriela Borges | Sell | Downgrade | $200.00 |
| Jan 17, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $270.00 |
| Jan 13, 2025 | Truist Securities | Jailendra Singh | Hold | Maintains | $210.00 |
| Jan 8, 2025 | Keybanc | Scott Schoenhaus | Overweight | Maintains | $255.00 |
| Dec 20, 2024 | Stephens & Co. | Jeff Garro | Overweight | Initiates | $0.00 |
| Dec 17, 2024 | Morgan Stanley | Craig Hettenbach | Underweight | Maintains | $195.00 |
| Dec 16, 2024 | JP Morgan | Anne Samuel | Neutral | Maintains | $218.00 |
| Dec 9, 2024 | Citigroup | Tyler Radke | Buy | Maintains | $307.00 |
| Dec 9, 2024 | Mizuho | Steven Valiquette | Outperform | Maintains | $280.00 |
| Dec 6, 2024 | Piper Sandler | Brent Bracelin | Overweight | Maintains | $290.00 |
| Dec 6, 2024 | Truist Securities | Jailendra Singh | Hold | Reiterates | $261.00 |
Veeva Systems Inc. (VEEV) Competitors
The following stocks are similar to Veeva based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Veeva Systems Inc. (VEEV) Financial Data
Veeva Systems Inc. has a market capitalization of $39.24B with a P/E ratio of 55.9x. The company generates $2.75B in trailing twelve-month revenue with a 26.0% profit margin.
Revenue growth is +14.3% quarter-over-quarter, while maintaining an operating margin of +26.1% and return on equity of +13.6%.
Valuation Metrics
Market Cap
$39.24B
Enterprise Value
$33.91B
P/E Ratio
55.9x
PEG Ratio
35.6x
Price/Sales
14.3x
Growth & Margins
Revenue Growth (YoY)
+14.3%
Gross Margin
+74.9%
Operating Margin
+26.1%
Net Margin
+26.0%
EPS Growth
+32.7%
Financial Health
Cash/Price Ratio
+13.5%
Current Ratio
4.5x
Debt/Equity
1.3x
ROE
+13.6%
ROA
+6.6%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Veeva Systems Inc. (VEEV) Business Model
About Veeva Systems Inc.
What They Do
Provides cloud software solutions for life sciences.
Business Model
Veeva Systems generates revenue by offering subscription-based software solutions tailored for the pharmaceutical, biotechnology, and medical device sectors. Their products enhance operational efficiency and regulatory compliance, catering to the specific needs of life sciences companies in areas such as clinical data management and commercial activities.
Additional Information
Founded in 2007 and headquartered in Pleasanton, California, Veeva Systems has positioned itself as a leader in the life sciences software market. The company's focus on digital transformation helps clients optimize research and development processes, thereby improving their overall market capabilities.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
7,291
CEO
Mr. Peter P. Gassner
Country
United States
IPO Year
2013
Website
www.veeva.comVeeva Systems Inc. (VEEV) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Veeva Systems (VEEV) closed the most recent trading day at $240.78, moving +0.48% from the previous trading session.
May 20, 2025
By Zacks Equity Research
Tale of the Tape
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates
P3 Health Partners (PIII) delivered earnings and revenue surprises of -25.60% and 2.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 15, 2025
By Zacks Equity Research
Tale of the Tape
Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Veeva Systems (VEEV) closed at $240.30, indicating a -0.37% shift from the previous trading day.
May 14, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Veeva Systems (NYSE: VEEV) announced that over 75 biotech companies are using Veeva Basics software to enhance efficiency and reduce costs in clinical, regulatory, and quality processes.
Why It Matters
Veeva Systems' growth in adoption of Veeva Basics by biotechs indicates strong demand for scalable solutions, potentially boosting revenue and market position, which is favorable for investors.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Veeva Systems (VEEV) closed at $240.78, up 0.48% from the prior trading session.
Why It Matters
Veeva Systems' slight price increase indicates positive market sentiment, which may attract more investors and suggest stability or growth potential in the stock.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
The Saudi Arabia Pharmaceutical Quality Management Software Market is expected to grow from $14.48M in 2024 to $26.92M by 2030, at a CAGR of 10.85%, driven by industry expansion and digital adoption.
Why It Matters
The projected growth of the Saudi pharmaceutical quality management software market indicates increasing opportunities for investment in tech and healthcare sectors, driven by innovation and regulatory compliance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Veeva Systems (VEEV) closed at $240.30, down 0.37% from the prior trading day.
Why It Matters
The slight decline in Veeva Systems' stock price may signal investor sentiment shifts, impacting future trading decisions and overall market perception of the company.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
xAI Holdings excels with AI innovation and Grok 3 launch. MercadoLibre shows strong revenue growth in Latin American e-commerce. Nvidia remains a strong investment despite stock correction.
Why It Matters
xAI Holdings' innovations and acquisitions enhance its market position. MercadoLibre's growth boosts e-commerce confidence, while Nvidia's strong fundamentals suggest resilience despite volatility.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Veeva Systems (VEEV) closed at $239.53, reflecting a 0.51% increase from the previous trading day.
Why It Matters
Veeva Systems' slight increase in stock price indicates stability, potentially reflecting positive market sentiment and investor confidence in the company's performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About VEEV Stock
What is Veeva Systems Inc.'s (VEEV) stock forecast for 2025?
Based on our analysis of 44 Wall Street analysts, Veeva Systems Inc. (VEEV) has a median price target of $270.00. The highest price target is $290.00 and the lowest is $201.00.
Is VEEV stock a good investment in 2025?
According to current analyst ratings, VEEV has 19 Buy ratings, 11 Hold ratings, and 2 Sell ratings. The stock is currently trading at $235.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VEEV stock?
Wall Street analysts predict VEEV stock could reach $270.00 in the next 12 months. This represents a 14.9% increase from the current price of $235.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Veeva Systems Inc.'s business model?
Veeva Systems generates revenue by offering subscription-based software solutions tailored for the pharmaceutical, biotechnology, and medical device sectors. Their products enhance operational efficiency and regulatory compliance, catering to the specific needs of life sciences companies in areas such as clinical data management and commercial activities.
What is the highest forecasted price for VEEV Veeva Systems Inc.?
The highest price target for VEEV is $290.00 from Brent Bracelin at Piper Sandler, which represents a 23.4% increase from the current price of $235.00.
What is the lowest forecasted price for VEEV Veeva Systems Inc.?
The lowest price target for VEEV is $201.00 from Craig Hettenbach at Morgan Stanley, which represents a -14.5% decrease from the current price of $235.00.
What is the overall VEEV consensus from analysts for Veeva Systems Inc.?
The overall analyst consensus for VEEV is bullish. Out of 44 Wall Street analysts, 19 rate it as Buy, 11 as Hold, and 2 as Sell, with a median price target of $270.00.
How accurate are VEEV stock price projections?
Stock price projections, including those for Veeva Systems Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 22, 2025 6:39 AM UTC